40 Hz Ultrasound for Health & Longevity - Quick Reference Sheet

40 Hz Ultrasound for Health & Longevity

Created on 07/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

An experimental, non-invasive approach that aims focused sound waves through the skull, switched on and off forty times a second, to strengthen the brain's fast rhythms, clear sticky plaques, and calm inflammation as the brain ages. Direct proof comes almost entirely from mice; it has never been tested in people, and benefits in healthy adults remain unproven. (Full Review)

Protocol

Carrier Frequency
~500 kHz
Delivered in tone bursts through the skull
Pulse Rate
40 Hz
Pulse-repetition frequency that defines the method
Session & Course
1–2 h daily, ~2 weeks
Preclinical regimen; human dosing not established
Time to effect
Brain Rhythms & Plaque
~2 weeks
Emerged over daily sessions in animal studies
Memory Gains
Persist ~5 days
After a course, in Alzheimer's-model mice
Human Time Course
Unknown
No rapid, perceptible effect expected

Benefits

Contraindications
  • Intracranial metal or implanted devices (aneurysm clips, shunts, deep-brain-stimulation hardware, cochlear implants)
  • Active or uncontrolled seizure disorder
  • Recent intracranial hemorrhage (within ~90 days) or known cerebral amyloid angiopathy
  • Skull defects or recent craniotomy
  • Pregnancy
Key Interactions
  • Other brain-stimulation methods (transcranial magnetic stimulation, transcranial direct-current stimulation, 40 Hz light/sound)
  • Seizure-threshold-lowering drugs (bupropion, tramadol, some antipsychotics)
  • Sedatives and anesthetics
  • Ultrasound contrast agents (microbubbles)
  • Blood-thinning supplements and drugs (high-dose fish oil, ginkgo, anticoagulants)

Risk & Side Effects

  • High:
  • Medium: Transient mild sensory and neurological effects
  • Low: Local thermal heating and skull bioeffects; off-target or unintended neuromodulation
  • Speculative: Blood-brain barrier disruption and microhemorrhage; seizure provocation; unknown long-term and cumulative effects

Monitoring

Marker Target Why
EEG 40 Hz gamma response Robust, reproducible 40 Hz steady-state response Confirms the brain is actually entraining to the stimulation
Cognitive composite (e.g., MoCA) 26–30 (MoCA) Tracks memory and thinking over time
Plasma p-tau217 Low / stable (assay-specific) Blood marker tracking Alzheimer's-type pathology
Plasma Aβ42/40 ratio Higher / stable (assay-specific) Reflects amyloid-β burden
Neurofilament light (NfL) Low for age (assay-specific) General marker of nerve-cell injury
hs-CRP < 1.0 mg/L Tracks systemic inflammation
Homocysteine < 7–8 µmol/L Elevated levels are linked to brain atrophy
Vitamin D (25-OH) 40–60 ng/mL Supports brain and immune health

Cadence: Baseline, then reassess at ~4–8 weeks after starting a course, and every 6–12 months thereafter; brain-rhythm and cognitive checks around each course.

Qualitative Assessment

  • Subjective memory and word-finding
  • Mental clarity and focus
  • Mood and motivation
  • Sleep quality and daytime energy